Trial Profile
A Phase 1, Randomized Trial to Compare the Oral Bioavailability of Indoximod Salt and Base Formulations and the Effect of Food (Part 1) and to Evaluate the PK and Safety of Single Ascending Doses of Indoximod (Part 2) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Mar 2019
Price :
$35
*
At a glance
- Drugs Indoximod (Primary)
- Indications Acute myeloid leukaemia; Breast cancer; Glioma; Malignant melanoma; Non-small cell lung cancer; Pancreatic cancer; Prostate cancer
- Focus Pharmacokinetics
- Sponsors NewLink Genetics Corporation
- 21 Feb 2019 Status changed from recruiting to completed.
- 26 Dec 2017 New trial record